22nd Century Group (XXII)

Executive Summary

22nd Century Group, Inc., a plant biotechnology company, provides technology that allows to alter the level of nicotine and other nicotinic alkaloids in tobacco plants, and cannabinoids in hemp/cannabis plants through genetic engineering and plant breeding. More Details

Risk Analysis

Earnings are forecast to decline by an average of 2% per year for the next 3 years

Currently unprofitable and not forecast to become profitable over the next 3 years

Volatile share price over the past 3 months

Shareholders have been diluted in the past year

Snowflake Analysis

Flawless balance sheet with weak fundamentals.

Similar Companies

Search for a company to compare.